tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Radiopharm reports cash balance of $34.52M as of December 31
The FlyRadiopharm reports cash balance of $34.52M as of December 31
2d ago
RADX
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
PremiumCompany Announcements
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
2d ago
RAD
Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
PremiumCompany Announcements
Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
8d ago
RAD
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
PremiumThe Fly
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
18d ago
RADX
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
PremiumCompany Announcements
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
1M ago
RAD
Radiopharm Theranostics Increases Director Paul Hopper’s Option Holdings After AGM Approval
PremiumCompany AnnouncementsRadiopharm Theranostics Increases Director Paul Hopper’s Option Holdings After AGM Approval
1M ago
RAD
Radiopharm Theranostics Increases Director Ian Turner’s Option Holdings After Shareholder Approval
Premium
Company Announcements
Radiopharm Theranostics Increases Director Ian Turner’s Option Holdings After Shareholder Approval
1M ago
RAD
Radiopharm Theranostics Issues 99.3 Million Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Radiopharm Theranostics Issues 99.3 Million Unquoted Options Under Employee Incentive Scheme
1M ago
RAD
Radiopharm Theranostics Announces Proposed Share Placement
PremiumCompany Announcements
Radiopharm Theranostics Announces Proposed Share Placement
1M ago
RAD
Radiopharm Theranostics Establishes ATM Facility to Expand U.S. Capital Fundraising Opportunities
PremiumCompany Announcements
Radiopharm Theranostics Establishes ATM Facility to Expand U.S. Capital Fundraising Opportunities
1M ago
RAD
Radiopharm Theranostics Addresses ASX Listing Rule Compliance Issue
PremiumCompany Announcements
Radiopharm Theranostics Addresses ASX Listing Rule Compliance Issue
1M ago
RAD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AIM
RADX
Radiopharm price target raised to $15 from $12 at Maxim
PremiumThe FlyRadiopharm price target raised to $15 from $12 at Maxim
1M ago
RADX
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
Premium
Ratings
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
1M ago
RADX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RADX
Radiopharm price target raised to $16 from $13 at B. Riley
PremiumThe Fly
Radiopharm price target raised to $16 from $13 at B. Riley
1M ago
RADX
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
PremiumThe Fly
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
2M ago
RADX
Radiopharm Theranostics’ RAD 101 Achieves Key Trial Milestone in Brain Metastases
PremiumCompany Announcements
Radiopharm Theranostics’ RAD 101 Achieves Key Trial Milestone in Brain Metastases
2M ago
RAD
Radiopharm Theranostics Announces Change in Substantial Holder Status
PremiumCompany Announcements
Radiopharm Theranostics Announces Change in Substantial Holder Status
2M ago
RAD
Radiopharm Theranostics Expands Share Issuance to Bolster Market Position
PremiumCompany AnnouncementsRadiopharm Theranostics Expands Share Issuance to Bolster Market Position
2M ago
RAD
Radiopharm Theranostics Announces New Securities Quotation on ASX
Premium
Company Announcements
Radiopharm Theranostics Announces New Securities Quotation on ASX
2M ago
RAD
Radiopharm Theranostics Announces New Securities Quotation on ASX
Premium
Company Announcements
Radiopharm Theranostics Announces New Securities Quotation on ASX
2M ago
RAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >